Lava Therapeutics shares delisted from Nasdaq following completion of acquisition By Investing.com
Lava Therapeutics shares delisted from Nasdaq following completion of acquisition
Lava Therapeutics shares delisted from Nasdaq following completion of acquisition
XOMA Royalty extends its tender offer for LAVA Therapeutics.
LAVA Therapeutics stock rises on acquisition deal with XOMA Royalty
XOMA Royalty to acquire HilleVax and LAVA Therapeutics in separate deals